Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,228 | 167 | 98.9% |
| Education | $36.52 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,296 | 77 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $316.61 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $264.49 | 12 | $0 (2024) |
| GENZYME CORPORATION | $213.35 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $189.35 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $160.01 | 9 | $0 (2020) |
| Shionogi Inc | $122.99 | 6 | $0 (2019) |
| Gilead Sciences Inc | $121.77 | 2 | $0 (2017) |
| Mauna Kea Technologies, Inc. | $114.17 | 3 | $0 (2021) |
| Allergan Inc. | $107.28 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $708.35 | 42 | ABBVIE INC. ($166.68) |
| 2023 | $752.25 | 38 | Regeneron Healthcare Solutions, Inc. ($209.16) |
| 2022 | $56.51 | 3 | ABBVIE INC. ($26.74) |
| 2021 | $114.17 | 3 | Mauna Kea Technologies, Inc. ($114.17) |
| 2020 | $106.76 | 7 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($44.04) |
| 2019 | $389.61 | 28 | AbbVie, Inc. ($144.84) |
| 2018 | $313.32 | 12 | AbbVie, Inc. ($111.14) |
| 2017 | $823.13 | 36 | AbbVie, Inc. ($640.63) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Immunology | ||||||
| 11/26/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/27/2024 | Phathom Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.48 | General |
| 10/22/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Immunology | ||||||
| 09/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Immunology | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $13.72 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Immunology | ||||||
| 07/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $99.21 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Immunology | ||||||
| 07/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/02/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.70 | General |
| Category: GI | ||||||
| 07/02/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 232 | 248 | $253,526 | $20,002 |
| 2022 | 7 | 190 | 208 | $190,245 | $17,342 |
| 2021 | 7 | 206 | 229 | $210,061 | $21,588 |
| 2020 | 3 | 49 | 52 | $47,958 | $3,940 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 43 | 43 | $68,413 | $7,859 | 11.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 62 | 69 | $79,557 | $4,007 | 5.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 57 | 57 | $76,437 | $2,824 | 3.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 13 | 15 | $21,570 | $1,539 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 17 | $1,666 | $1,219 | 73.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 13 | $2,380 | $1,022 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 20 | $2,565 | $929.93 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 14 | $937.50 | $601.08 | 64.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 27 | 27 | $42,957 | $4,846 | 11.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 52 | 58 | $66,874 | $3,631 | 5.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 41 | $5,535 | $2,562 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 21 | $4,116 | $1,829 | 44.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 35 | 35 | $46,935 | $1,651 | 3.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,696 | $1,496 | 40.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 13 | 14 | $20,132 | $1,327 | 6.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 30 | 30 | $47,730 | $5,694 | 11.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 62 | 68 | $78,404 | $5,313 | 6.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 52 | 52 | $69,732 | $3,640 | 5.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 30 | $5,250 | $2,932 | 55.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 22 | $2,640 | $1,472 | 55.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,575 | $1,463 | 40.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $2,730 | $1,074 | 39.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 23 | 24 | $27,672 | $1,967 | 7.1% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 14 | 14 | $18,774 | $1,185 | 6.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 12 | 14 | $1,512 | $787.81 | 52.1% |
About Dr. Kaely Bade, M.D
Dr. Kaely Bade, M.D is a Gastroenterology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2012. The National Provider Identifier (NPI) number assigned to this provider is 1689933103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kaely Bade, M.D has received a total of $3,264 in payments from pharmaceutical and medical device companies, with $708.35 received in 2024. These payments were reported across 169 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,228).
As a Medicare-enrolled provider, Bade has provided services to 677 Medicare beneficiaries, totaling 737 services with total Medicare billing of $62,871. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Fort Wayne, IN
- Active Since 05/04/2012
- Last Updated 10/15/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1689933103
Products in Payments
- Humira (Biological) $519.80
- DUPIXENT (Biological) $477.84
- SKYRIZI (Biological) $283.97
- ENTYVIO (Biological) $232.32
- Mavyret (Drug) $161.51
- ZENPEP (Drug) $145.96
- STELARA (Biological) $105.80
- Epclusa (Drug) $104.43
- Entyvio (Biological) $95.25
- Mulpleta (Drug) $93.24
- Viekira (Drug) $88.13
- XIFAXAN (Drug) $80.94
- EOHILIA (Drug) $49.77
- TREMFYA (Drug) $49.56
- FERAHEME (Drug) $36.52
- REMICADE (Biological) $33.99
- SUCRAID (Drug) $32.37
- Symproic (Drug) $29.75
- LINZESS (Drug) $28.24
- TRULANCE (Drug) $27.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Wayne
Dr. Efesomwan Aisien, M.d, M.D
Gastroenterology — Payments: $89,557
Dr. Abdo Saad, Md, MD
Gastroenterology — Payments: $59,492
Melissa Garrett, Md, MD
Gastroenterology — Payments: $59,090
Dr. Mariajose Rojas De Leon, Md, MD
Gastroenterology — Payments: $39,782
Dr. Kirsten Weiser, M.d, M.D
Gastroenterology — Payments: $20,935
Dr. David Gutman, Md, Facg, MD, FACG
Gastroenterology — Payments: $13,732